CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression [Phase 3]
Summary
Phase 3 trial update for celecoxib in hip osteoarthritis has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis | Phase 3 | Status: TERMINATED